Gene · 593
Papers1,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison Between Dichloroacetate and Phenylbutyrate Treatment for Pyruvate Dehydrogenase Deficiency. | Br J Biomed Sci | 2022 | 35996497 | PubTator, text mining | PubMed |
| Unusual Reactivities of ortho-Hydroxy-β-nitrostyrene. | Molecules | 2022 | 35956754 | PubTator, text mining | PubMed |
| Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development. | Cancers (Basel) | 2022 | 35954433 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Generalized dystonia without Parkinsonism in an LRRK2 carrier. | Clin Park Relat Disord | 2022 | 35941989 | PubTator, text mining | PubMed |
| Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms. | Front Microbiol | 2022 | 35935188 | PubTator, text mining | PubMed |
| Ras Participates in the Regulation of the Stability of Adenoviral Protein E1A via MAP-kinase ERK. | Acta Naturae | 2022 | 35923563 | PubTator, text mining | PubMed |
| Functional Versatility of the Human 2-Oxoadipate Dehydrogenase in the L-Lysine Degradation Pathway toward Its Non-Cognate Substrate 2-Oxopimelic Acid. | Int J Mol Sci | 2022 | 35897808 | PubTator, text mining | PubMed |
| Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer. | Bioengineering (Basel) | 2022 | 35892755 | PubTator, text mining | PubMed |
| Oxidative Glucose Metabolism Promotes Senescence in Vascular Endothelial Cells. | Cells | 2022 | 35883656 | PubTator, text mining | PubMed |
| Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients. | Vet Sci | 2022 | 35878344 | PubTator, text mining | PubMed |
| Identification of a Novel Heterozygous Mutation in the EIF2B4 Gene Associated With Vanishing White Matter Disease. | Front Bioeng Biotechnol | 2022 | 35860328 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| 3D Genome Organization as an Epigenetic Determinant of Transcription Regulation in T Cells. | Front Immunol | 2022 | 35812421 | PubTator, text mining | PubMed |
| Genomic and biochemical analysis of repeatedly observed variants in DBT in individuals with maple syrup urine disease of Central American ancestry. | Am J Med Genet A | 2022 | 35799415 | PubTator, text mining | PubMed |
| Simulations of Pathogenic E1α Variants: Allostery and Impact on Pyruvate Dehydrogenase Complex-E1 Structure and Function. | J Chem Inf Model | 2022 | 35797142 | PubTator, text mining | PubMed |
| PKAN hiPS-Derived Astrocytes Show Impairment of Endosomal Trafficking: A Potential Mechanism Underlying Iron Accumulation. | Front Cell Neurosci | 2022 | 35783094 | PubTator, text mining | PubMed |
| Domino liver transplant from a donor with maple syrup urine disease into a recipient with phenylketonuria. | Mol Genet Metab Rep | 2022 | 35782613 | PubTator, text mining | PubMed |
| The Pyruvate Dehydrogenase Complex Mitigates LPS-Induced Endothelial Barrier Dysfunction by Metabolic Regulation. | Shock | 2022 | 35759309 | PubTator, text mining | PubMed |
| Strong Selectional Forces Fine-Tune CpG Content in Genes Involved in Neurological Disorders as Revealed by Codon Usage Patterns. | Front Neurosci | 2022 | 35757545 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/593/papers?page=11